OmniAb (OABI) Total Liabilities (2021 - 2026)
OmniAb (OABI) posted quarterly Total Liabilities of $31.0 million for Q1 2026, down 5.09% year-over-year from $32.7 million in Q1 2025, and down 8.51% quarter-over-quarter from $33.9 million in Q4 2025.
OmniAb (OABI) Total Liabilities (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Total Liabilities for 6 consecutive years, with $31.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 5.09% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $31.0 million (down 5.09% YoY), while the FY2025 annual figure was $33.9 million, down 10.68% from the prior year.
- Total Liabilities fell to $31.0 million in Q1 2026 per OABI's latest filing, from $33.9 million in the prior quarter.
- Across five years, Total Liabilities topped out at $79.8 million in Q4 2022 and bottomed at $13.5 million in Q1 2022.
- Historically, Total Liabilities has averaged $42.9 million across 5 years, with a median of $37.9 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 2330.29% — and 2024, when it sank 40.7%.
- OmniAb's Total Liabilities stood at $79.8 million in 2022, then dropped by 24.05% to $60.6 million in 2023, then tumbled by 37.43% to $37.9 million in 2024, then dropped by 10.68% to $33.9 million in 2025, then decreased by 8.51% to $31.0 million in 2026.
- Business Quant data shows OABI's Total Liabilities at $31.0 million in Q1 2026, $33.9 million in Q4 2025, and $32.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | 29.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.98 Mn |
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 33.89 Mn |
| Sep 30, 2025 | 32.25 Mn |
| Jun 30, 2025 | 33.61 Mn |
| Mar 31, 2025 | 32.67 Mn |
| Dec 31, 2024 | 37.94 Mn |
| Sep 30, 2024 | 39.83 Mn |
| Jun 30, 2024 | 43.08 Mn |
| Mar 31, 2024 | 51.16 Mn |
| Dec 31, 2023 | 60.64 Mn |
| Sep 30, 2023 | 67.16 Mn |
| Jun 30, 2023 | 71.43 Mn |
| Mar 31, 2023 | 72.24 Mn |
| Dec 31, 2022 | 79.84 Mn |
| Sep 30, 2022 | 14.29 Mn |
| Jun 30, 2022 | 15.03 Mn |
| Mar 31, 2022 | 13.51 Mn |
| Dec 31, 2021 | 70.16 Mn |
| Sep 30, 2021 | 8.15 Mn |